Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Preventing Depression in the Children of Depressed African American Mothers

17 octobre 2014 mis à jour par: Rhonda Boyd, Children's Hospital of Philadelphia

Children of Depressed Mothers: Culture & Prevention

The purpose of the study is to adapt and test the Preventive Intervention Project for urban African American mothers with depression and their children.

Aperçu de l'étude

Description détaillée

Abstract

Background: There is limited representation of ethnic minorities in preventive interventions for the generational impact of maternal depression.

Methods: The Preventive Intervention Project (PIP) was adapted to be culturally and contextually relevant for urban African American mothers with depression and their children. A pilot clinical trial (PIP vs. lecture) was conducted.

Type d'étude

Interventionnel

Inscription (Réel)

34

Phase

  • La phase 1

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Pennsylvania
      • Philadelphia, Pennsylvania, États-Unis, 19104
        • The Children's Hospital of Philadelphia

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

8 ans à 14 ans (Enfant)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Mothers:

Inclusion Criteria:

  • African American
  • Primary current or past-year diagnostic and statistical manual (DSM-IV) diagnosis of Major Depressive Disorder, Dysthymic Disorder, or Depressive Disorder not otherwise specified
  • Parent or guardian and primary caregiver of a child 8 to 14 years old
  • Resided at least part time for the past year with the targeted child
  • May be receiving psychopharmacological treatment, psychosocial services, or both

Exclusion Criteria:

  • Current or lifetime history of schizophrenia
  • Current or lifetime history of bipolar disorder
  • Current or past-year diagnosis of alcohol or drug dependency
  • Serious medical disorder, neurological disorder, condition, or chronic pain that prevents participation
  • Documented mental retardation
  • Current suicide risk sufficient to preclude outpatient treatment

Children:

Inclusion Criteria:

  • Have an African American mother with a depressive disorder
  • 8 to 14 years old
  • Reside at least part time with mother

Exclusion Criteria:

  • Currently in treatment for depression or an anxiety disorder
  • Presence of a medical or psychiatric condition contraindicating study intervention, such as mental retardation, suicidality, or pervasive developmental disorder

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Adapted PIP

Participants (both mother and children) participated in an adapted cognitive family prevention program for the families of children with a depressed African American mother.

The intervention was the Prevention Intervention Project.

Eight 1-hour sessions focused on psychoeducation, coping with stress, and cognitive-behavioral strategies. The sessions were tailored as required to meet the clinical and cultural needs of each family; other family members, such as fathers, spouses, and grandparents, were invited to participate in the intervention.
Comparateur actif: Lecture

Mothers received psychoeducation about depression.

The intervention was psychoeducation.

Two 1-hour sessions focusing on psychoeducation about depression and its impact on children and the family.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Children Depression Inventory (CDI)
Délai: Measured at baseline and at post-treatment (8 weeks after baseline)
Children Depression Inventory (CDI; Kovacs, 1992) is a widely-used self-report scale of depressive symptoms suitable for use by youth ranging from 7 to 17 years. The CDI is a 27-item scale that is self-rated and symptom-oriented. The 27 items on the assessment are grouped into five major factor areas. The item score are rated 0-2 with a total scores summed and converted to T scores. The total T score ranges from 33 to 100 with high scores indicating higher levels of depressive symptoms.
Measured at baseline and at post-treatment (8 weeks after baseline)
Multidimensional Anxiety Scale for Children (MASC)
Délai: Measured at baseline and post-treatment (8 weeks after baseline)
Multidimensional Anxiety Scale for Children (MASC; March et al., 1997) is a self-report instrument that measures a broad range of anxiety symptoms in youth. The MASC consists of 39 items using a 4-point Likert scale that are distributed across four major factors, three of which can be parsed into two subfactors each. Main and subfactors include (1) physical symptoms (tense/restless and somatic/autonomic), (2) social anxiety (humiliation/rejection and public performance fears), (3) harm avoidance (perfectionism and anxious coping), and (4) separation anxiety. Scores are summed and converted to T-scores. The total T score ranges from 25 to 90 with higher scores representing greater levels of anxiety.
Measured at baseline and post-treatment (8 weeks after baseline)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Understanding Mood Disorders Questionnaire (UMDQ)
Délai: Measured at baseline and post-treatment (8 weeks after baseline)
Understanding Mood Disorders Questionnaire (UMDQ; Gavazzi, Fristad, & Law, 1997) measures attributions and knowledge of symptoms, course, and treatment of mood disorders and a symptom checklist. It has 39 items and two subscales. A range of total score is 0 to 59. The first 20 questions are true/false questions and correct responses are scored 2 points each. Nineteen questions are a checklist of symptoms and correct identification of those depression and manic symptoms are scored 1 point each. All items are summed for a total score. Higher scores indicate greater knowledge of mood disorders. Both maternal and child reporters completed this measure.
Measured at baseline and post-treatment (8 weeks after baseline)
Child's Report on Parental Behavior Inventory (CRPBI)
Délai: Measured at baseline and post-treatment (8 weeks after baseline)
Child's Report on Parental Behavior Inventory (CRPBI; Schludermann & Schludermann, 1970) assesses children's and parents' perceptions of parental acceptance, permitting psychological autonomy, and level of parental control. The 10-item acceptance scale which assesses parental warmth was administered. The acceptable scale has items scored from 1 to 3 (not like me, somewhat like me, a lot like me). Items are summed with a total range is 10 to 30. Higher scores represents greater warmth exhibited by mother to child. Separate forms are available for both child and parent report.
Measured at baseline and post-treatment (8 weeks after baseline)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Rhonda C. Boyd, PhD, Children's Hospital of Philadelphia

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 février 2008

Achèvement primaire (Réel)

1 février 2009

Achèvement de l'étude (Réel)

1 février 2009

Dates d'inscription aux études

Première soumission

19 mai 2009

Première soumission répondant aux critères de contrôle qualité

19 mai 2009

Première publication (Estimation)

20 mai 2009

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

20 octobre 2014

Dernière mise à jour soumise répondant aux critères de contrôle qualité

17 octobre 2014

Dernière vérification

1 octobre 2014

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2004-10-4041
  • K01MH068619 (Subvention/contrat des NIH des États-Unis)
  • DSIR 8K-RTCT (NIMH DSIR)
  • IRB NO: 2004-10-4041 (Autre identifiant: IRB No.)

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Prevention Intervention Project

3
S'abonner